Skip to main content
OpenTrials
Completed

NCT Number: NCT01655576

Effectiveness of Placental Drainage in the Third Stage of Labor: a Randomized Clinical Trial

The purpose of this study is to determine if placental drainage shortens third period of labor and reduces postpartum blood lost.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Management of Delivery Female Urogenital Diseases and Pregnancy Complications Hemorrhage Obstetric Labor Complications Pathologic Processes Pathological Conditions, Signs and Symptoms Postpartum Hemorrhage Pregnancy Complications Puerperal Disorders Urogenital Diseases Uterine Hemorrhage

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

IMIP

Recife, Pernambuco, 50.000, Brazil

About this study

The study aims to compare the effectiveness of placental drainage versus maintenance of maternal cord clamped end in the third stage of labor to reduce postpartum blood loss.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Low risk pregnant women
  • Pregnancy at term
  • Women at low risk for assisted labor / delivery and postpartum care.
  • Live Fetus

Exclusion criteria

  • Women under 18, mentally handicapped and indigenous;
  • Women who agreed to participate signed the Informed Consent, but evolved to cesarean section or instrumental delivery by forceps;
  • Instrumental Delivery by forceps or c-section

Treatment and study plan

Placental drainage

Procedure

After delivery of the newborn, umbilical cord at mothers end, will be left unclamped until delivery of the placenta.

Primary outcomes

  1. Duration of the third period of labor

    Time frame: Six hours

    Time from delivery of the baby to the delivery of the placenta

Secondary outcomes

  1. Postpartum blood loss

    Time frame: 24 hours

    Volume of blood lost 24 hours after birth

  2. PPH

    Time frame: 24 hours

    Postpartum hemorrhage

  3. Need of uterotonics

    Time frame: 24 hours

    use of aditional uterotonics ( prophylkatic use not included)

  4. Need of blood transfusions

    Time frame: until discharge

    Need of blood transfusions

Sponsors and collaborators

Lead sponsor

Instituto Materno Infantil Prof. Fernando Figueira

Other

Registry information

Acronym: PLADRAINAGE

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Aug 2, 2012
Registry last updated
Jun 5, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.